ResearcherAsahikawa Medical UniversityNo recent work listed

Akemi Kita

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5061075666. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper

Papers 1

Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells. Co-author DOI 10.3892/ijo.2020.5096 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mikihiro Fujiya · 1 shared paper, 2020 · strength 0.09
- Paper Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells. DOI 10.3892/ijo.2020.5096 ↗
Hiroaki Konishi · 1 shared paper, 2020 · strength 0.09
- Paper Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells. DOI 10.3892/ijo.2020.5096 ↗
Toshikatsu Okumura · 1 shared paper, 2020 · strength 0.09
- Paper Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells. DOI 10.3892/ijo.2020.5096 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.